A. Pham-Ledard

发表

Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients

N. Dupin, O. Chosidow, M. Beylot-Barry, 2017, European Journal of Dermatology.

Central nervous system involvement of primary cutaneous diffuse large B‐cell lymphoma, leg type: 13 cases

A. Maraval, M. Beylot-Barry, E. Durot, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients.

S. Prey, C. Dutriaux, M. Molimard, 2017, Clinica chimica acta; international journal of clinical chemistry.

Lymphomatoid papulosis type D: an aggressive histology for an indolent disease

M. Beylot-Barry, A. Bertolotti, M. Parrens, 2013, The British journal of dermatology.

Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors

M. Beylot-Barry, S. Prey, T. Schaeverbeke, 2022, Cancer Immunology, Immunotherapy.

Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study

M. Beylot-Barry, S. Prey, C. Dutriaux, 2021, Journal of oncology.

Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes

D. Cappellen, Alice Bibeyran, F. Moreau-Gaudry, 2016, Oncotarget.

IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.

T. Jouary, J. Merlio, M. Beylot-Barry, 2010, The Journal of investigative dermatology.

Reliable blood cancer cells' telomere length evaluation by qPCR

D. Cappellen, Y. Idrissi, J. Merlio, 2020, Cancer medicine.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

L. Misery, C. Robert, L. Chiche, 2019, Arthritis & rheumatology.

Proliferative tumor infiltrating lymphocytes abundance within microenvironment impact clinical outcome in cutaneous B-cell lymphomas.

C. Rey, J. Merlio, M. Beylot-Barry, 2022, The Journal of investigative dermatology.

High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.

T. Petrella, D. Cappellen, J. Merlio, 2014, JAMA dermatology.

The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

M. Weichenthal, U. Wehkamp, C. Klemke, 2018, The British journal of dermatology.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

R. Cowan, J. Scarisbrick, A. Pileri, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of diagnostic criteria between primary cutaneous anaplastic large‐cell lymphoma and CD30‐rich transformed mycosis fungoides; a study of 66 cases

D. Cappellen, J. Merlio, S. Dalle, 2015, The British journal of dermatology.

18F-FDG PET/CT Imaging of Popliteal Vasculitis Associated With Polyarteritis Nodosa.

P. Fernandez, P. Mercié, J. Pinaquy, 2017, Clinical nuclear medicine.

Clinical, biological and histological characteristics of bullous pemphigoid associated with anti‐PD‐1/PD‐L1 therapy: A national retrospective study

B. Dréno, G. Jeudy, M. Viguier, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma

M. Beylot-Barry, S. Prey, C. Dutriaux, 2019, Cancer Immunology, Immunotherapy.

Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis.

M. Beylot-Barry, A. Marti, A. Pham-Ledard, 2016, JAMA dermatology.

Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.

S. Prey, C. Dutriaux, M. Molimard, 2017, Clinica chimica acta; international journal of clinical chemistry.

Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanoma.

M. Beylot-Barry, S. Prey, N. Meyer, 2020, Journal of geriatric oncology.

Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas

E. Chouery, C. Farra, E. Ségal-Bendirdjian, 2021, Molecular oncology.

Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry *

T. Petrella, P. Courville, L. Michel, 2020, The British journal of dermatology.

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity

A. Gros, J. Merlio, M. Beylot-Barry, 2020, Leukemia.

Anti‐PD1‐induced psoriasis: a study of 21 patients

G. Jeudy, P. Combemale, E. Mahé, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Anti-PD 1-induced psoriasis . A study of 21 patients Short title : Anti-PD 1-induced psoriasis

G. Jeudy, P. Combemale, E. Mahé, 2016 .

Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors

M. Beylot-Barry, S. Prey, T. Schaeverbeke, 2022, Cancer Immunology, Immunotherapy.

Lack of clinical relevance of blood clonality in primary cutaneous marginal zone B-cell lymphoma

P. Dubus, J. Merlio, M. Beylot-Barry, 2021, European Journal of Dermatology.

[Facial confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome) or hyperkeratotic head and neck Malassezia dermatitis?].

H. Bégueret, F. Boralevi, K. Ezzedine, 2010, Annales de dermatologie et de venereologie.

Intravenous cidofovir for diffuse genital warts in the setting of multifactorial immunosuppression

M. Beylot-Barry, A. Dutkiewicz, A. Pham-Ledard, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Characteristics, Associated Diseases, and Management of Gram-negative Toe-web Infection: A French Experience.

O. Chosidow, M. Beylot-Barry, B. Milpied, 2019, Acta dermato-venereologica.

A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma

J. Vial, A. Gros, M. Beylot-Barry, 2022, Acta dermato-venereologica.

Pyoderma gangrenosum with extensive pulmonary involvement

M. Beylot-Barry, M. Doutre, A. Pham-Ledard, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group

M. Boubaya, L. Misery, D. Spaeth, 2021, Cancers.

Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma.

M. Beylot-Barry, S. Prey, C. Dutriaux, 2021, Journal of geriatric oncology.

Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study

T. Barnetche, M. Beylot-Barry, S. Prey, 2021, JAAD international.